Evidence map›Paper›PMID 37541259›Full record

ArticleStem cell reports2023

VE-CADHERIN is expressed transiently in early ISL1

Violetta A Maltabe, Anna N Melidoni, Dimitris Beis, Ioannis Kokkinopoulos, Nikolaos Paschalidis, Panos Kouklis

Open access · goldAbstract read
In one paragraph

Article in Stem cell reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Violetta A MaltabeLaboratory of Biology, Department of Medicine, University of Ioannina, Ioannina, Greece; Division of Biomedical Research, Foundation for Research and Technology, Institute of Molecular Biology and Biotechnology, Ioannina, Greece.
Anna N MelidoniLaboratory of Biology, Department of Medicine, University of Ioannina, Ioannina, Greece.
Dimitris BeisDevelopmental Biology, Center for Experimental Surgery Clinical and Translational Research, Biomedical Research Foundation Academy of Athens (BRFAA), 11527 Athens, Greece; Laboratory of Biochemistry, Department of Medicine, University of Ioannina, Ioannina, Greece.
Ioannis KokkinopoulosDevelopmental Biology and Immunobiology Laboratories, Center for Clinical, Experimental Surgery, and Translational Research, Biomedical Research Foundation of the Academy of Athens, 11527 Athens, Greece.
Nikolaos PaschalidisCenter for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, 115 27 Athens, Greece.
Panos KouklisLaboratory of Biology, Department of Medicine, University of Ioannina, Ioannina, Greece; Division of Biomedical Research, Foundation for Research and Technology, Institute of Molecular Biology and Biotechnology, Ioannina, Greece. Electronic address: pkouklis@uoi.gr.
University of Ioannina · GRBiomedical Research Foundation of the Academy of Athens · GRAcademy of Athens · GR

Funding

Wellcome Trust
6 · The paper itself

Abstract

Adherens junctions (AJs) provide adhesive properties through cadherins and associated cytoplasmic catenins and participate in morphogenetic processes. We examined AJs formed between ISL1

Indexed as

Antigens, CDCadherinsHeartAnimalsCadherin 5Cell DifferentiationEmbryonic Stem CellsMiceAntigens, CDCadherin 5CadherinsAdherens JunctionsCadherinsCardiac progenitorsEmbryonic Stem CellsFLK1ISL1MEF2CN-CADHERINVE-CADHERIN

Identifiers

PMID37541259
PMCPMC10545488
OpenAlexW4385547542

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.